Biosimilars are a growing area in the pharmaceutical field and are set to expand over the next decade. According to Netscribes research, by 2022, the global biosimilar market is expected to reach USD 36 billion, while the biologic market is e...

Biosimilars have the potential to rein in branded drug costs and promote cost effective patient care. However, the successful realization of these prospects have neither been easy nor assured....